PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus

Published:2017-04-04 Issue:4 Volume:46 Page:409-418
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Abbasi Farzaneh,Soltani Samaneh,Saghazadeh Amene,Soltaninejad Ehsan,Rezaei Arezou,Zare Bidoki Alireza,Bahrami Tayyeb,Amirzargar Ali Akbar,Rezaei Nima

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2017.1288239

Reference60 articles.

1. Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant

2. Analysis of PTPN22 C1858T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran

3. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

4. KIR gene content diversity in four Iranian populations

5. Type 1 diabetes: new perspectives on disease pathogenesis and treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CTSG polymorphisms in Chinese children with type 1 diabetes mellitus;Journal of Tropical Pediatrics;2024-07-13

2. Genetic association of PTPN22 polymorphisms with Type 1 diabetes in Pakistani children;Journal of King Saud University - Science;2023-12

3. PTPN22 intron polymorphism rs1310182 (c.2054-852T>C) is associated with type 1 diabetes mellitus in patients of Armenian descent;PLOS ONE;2023-06-14

4. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy;Signal Transduction and Targeted Therapy;2022-06-04

5. Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population;Human Genomics;2022-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3